Abstract
A new coronavirus called SARS-CoV-2 is rapidly spreading around the world. Over 16,558,289 infected cases with 656,093 deaths have been reported by July 29th, 2020, and it is urgent to identify effective antiviral treatment. In this study, potential antiviral drugs against SARS-CoV-2 were identified by drug repositioning through Virus-Drug Association (VDA) prediction. 96 VDAs between 11 types of viruses similar to SARS-CoV-2 and 78 small molecular drugs were extracted and a novel VDA identification model (VDA-RLSBN) was developed to find potential VDAs related to SARS-CoV-2. The model integrated the complete genome sequences of the viruses, the chemical structures of drugs, a regularized least squared classifier (RLS), a bipartite local model, and the neighbor association information. Compared with five state-of-the-art association prediction methods, VDA-RLSBN obtained the best AUC of 0.9085 and AUPR of 0.6630. Ribavirin was predicted to be the best small molecular drug, with a higher molecular binding energy of -6.39 kcal/mol with human angiotensin-converting enzyme 2 (ACE2), followed by remdesivir (-7.4 kcal/mol), mycophenolic acid (-5.35 kcal/mol), and chloroquine (-6.29 kcal/mol). Ribavirin, remdesivir, and chloroquine ha...Continue Reading
References
Apr 16, 1987·Nature·M GuyaderM Alizon
Jan 12, 1995·Nature·X WeiB H Hahn
Jan 1, 1996·Journal of Molecular Recognition : JMR·D S GoodsellA J Olson
Feb 7, 1998·Science·K SubbaraoN Cox
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Jun 23, 2001·The New England Journal of Medicine·C B Hall
May 14, 2004·The Journal of Pathology·Yanqing DingShibo Jiang
Jul 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Matthew I BonaparteChristopher C Broder
Jul 17, 2009·Bioinformatics·Kevin Bleakley, Yoshihiro Yamanishi
Oct 14, 2009·JAMA : the Journal of the American Medical Association·Anand KumarUNKNOWN Canadian Critical Care Trials Group H1N1 Collaborative
Sep 25, 2010·BMC Systems Biology·Zheng XiaStephen T C Wong
Jun 24, 2011·The New England Journal of Medicine·Ira M JacobsonUNKNOWN ADVANCE Study Team
Apr 28, 2012·Molecular BioSystems·Xing ChenGui-Ying Yan
May 17, 2013·Journal of Virology·Raoul J de GrootJohn Ziebuhr
May 24, 2013·The New England Journal of Medicine·Hai-Nv GaoLan-Juan Li
Jul 11, 2013·PloS One·Twan van Laarhoven, Elena Marchiori
Aug 19, 2015·Briefings in Bioinformatics·Xing ChenYongdong Zhang
Jan 6, 2016·IEEE Journal of Biomedical and Health Informatics·Lihong PengKeqin Li
Jun 23, 2016·Oncotarget·Jie LiYun Tang
Jul 9, 2016·Advances and Applications in Bioinformatics and Chemistry : AABC·Jerome de RuyckMarc F Lensink
Jul 9, 2016·IEEE/ACM Transactions on Computational Biology and Bioinformatics·Wei LanYi Pan
Nov 11, 2017·Nucleic Acids Research·David S WishartMichael Wilson
Nov 6, 2018·Molecular Therapy. Nucleic Acids·Qi ZhaoHongsheng Liu
Oct 1, 2019·Transplantation·Nitipong PermpalungBarbara D Alexander
Oct 12, 2019·Nucleic Acids Research·Eric W SayersJames Ostell
Jan 25, 2020·The Journal of Infectious Diseases·Frederick G Hayden, Richard J Whitley
Jan 28, 2020·Lancet·Chaolin HuangBin Cao
Jan 30, 2020·Journal of Medical Virology·Weier WangFangqiang Wei
Jan 31, 2020·Bioscience Trends·Hongzhou Lu
Feb 6, 2020·Cell Research·Manli WangGengfu Xiao
Feb 6, 2020·Chembiochem : a European Journal of Chemical Biology·Jared S MorseWenshe Ray Liu
Mar 3, 2020·Frontiers in Bioengineering and Biotechnology·Li-Hong PengXue Piao
Mar 5, 2020·Nature Reviews. Drug Discovery·Guangdi Li, Erik De Clercq
Apr 2, 2020·The Journal of Clinical Endocrinology and Metabolism·Ursula B KaiserPaul M Stewart
Apr 14, 2020·Computational and Structural Biotechnology Journal·Bo Ram BeckKeunsoo Kang